Lung Adenocarcinoma EGFR, KRAS and BRAF Mutational Analysis, Histologic Correlation and Longitudinal Review

被引：0
|
作者：
Wachsmann, M. B. [1 ]
Glass, C. [1 ]
Butt, Y. M. [1 ]
Yan, S. [1 ]
Torrealba, J. [1 ]
Gokaslan, T. [1 ]
Sarode, V. [1 ]
Gerber, D. [1 ]
Dowell, J. [1 ]
Hughes, R. [1 ]
Kernstine, K. [1 ]
Abu-Hijleh, M. [1 ]
Chiu, H. [1 ]
Oliver, D. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2018年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST122
引用
收藏
页码：1006 / 1006
页数：1
相关论文
共 50 条
  • [1] EGFR, KRAS, and BRAF mutational profiles of female patients with micropapillary predominant invasive lung adenocarcinoma
    Demirag, Funda
    Yilmaz, Aydin
    Yilmaz Demirci, Nilgun
    Yilmaz, Ulku
    Erdogan, Yurdanur
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (05) : 1354 - 1361
  • [2] EGFR and KRAS Mutational Analyses in Metastatic Lung Adenocarcinoma
    Munfus-McCray, Delicia
    Askin, Frederic
    Clark, Douglas
    Adams, Christina
    Gabrielson, Edward
    Li, Qing Kay
    [J]. CANCER CYTOPATHOLOGY, 2010, 118 (05) : 369 - 369
  • [3] EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
    Szablewski, Vanessa
    Solassol, Jerome
    Poizat, Flora
    Larrieux, Marion
    Crampette, Louis
    Mange, Alain
    Bascoul-Mollevi, Caroline
    Costes, Valerie
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (03): : 5170 - 5181
  • [4] EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
    Szablewski, V.
    Solassol, J.
    Crampette, L.
    Larieux, M.
    Tempier, A.
    Costes, V.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 314A - 314A
  • [5] EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
    Szablewski, V.
    Solassol, J.
    Crampette, L.
    Larieux, M.
    Tempier, A.
    Costes, V.
    [J]. MODERN PATHOLOGY, 2013, 26 : 314A - 314A
  • [6] Micropapillary Lung Adenocarcinoma EGFR, K-ras, and BRAF Mutational Profile
    Achcar, Rosane De Oliveira Duarte
    Nikiforova, Marina N.
    Yousem, Samuel A.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (05) : 694 - 700
  • [7] Analysis of KRAS, BRAF, and EGFR mutational status in respiratory epithelial adenomatoid hamartoma (REAH)
    Guimaraes, Leticia Martins
    Vieira, Tamara da Silva
    De Marco, Luiz Armando
    Thompson, Lester D. R.
    Gomes, Carolina Cavalieri
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2023, 52 (06) : 548 - 553
  • [8] An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients
    Prencipe, Berardino
    Delprete, Claudia
    Garolla, Emilio
    Corallo, Fabio
    Gravina, Matteo
    Natalicchio, Maria Iole
    Buongiorno, Domenico
    Bevilacqua, Vitoantonio
    Altini, Nicola
    Brunetti, Antonio
    [J]. BIOENGINEERING-BASEL, 2023, 10 (07):
  • [9] EGFR and KRAS Mutational Analysis and Their Correlation to Survival in Pancreatic and Periampullary Cancer
    Oliveira-Cunha, Melissa
    Hadfield, Kristen D.
    Siriwardena, Ajith K.
    Newman, William
    [J]. PANCREAS, 2012, 41 (03) : 428 - 434
  • [10] EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
    Maria Colombino
    Panagiotis Paliogiannis
    Antonio Cossu
    Davide Adriano Santeufemia
    Maria Cristina Sini
    Milena Casula
    Grazia Palomba
    Antonella Manca
    Marina Pisano
    Valentina Doneddu
    Giuseppe Palmieri
    [J]. BMC Pulmonary Medicine, 19
12345